Cita APA

Butrym, A., Rybka, J., Baczyńska, D., Poręba, R., Kuliczkowski, K., & Mazur, G. (2016). Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients. Oncotarget.

Chicago Style Citation

Butrym, Aleksandra, Justyna Rybka, Dagmara Baczyńska, Rafał Poręba, Kazimierz Kuliczkowski, i Grzegorz Mazur. "Clinical Response to Azacitidine Therapy Depends On MicroRNA-29c (miR-29c) Expression in Older Acute Myeloid Leukemia (AML) Patients." Oncotarget 2016.

Cita MLA

Butrym, Aleksandra, et al. "Clinical Response to Azacitidine Therapy Depends On MicroRNA-29c (miR-29c) Expression in Older Acute Myeloid Leukemia (AML) Patients." Oncotarget 2016.